ZeBraInspector, a platform for the automated segmentation and analysis of body and brain volumes in whole 5 dpf zebrafish following simultaneous visualization with identical orientations
Fiche du document
20 mai 2024
- handle: 10670/1.mz045d
- hal: hal-04580401
- BIORXIV: 2020.10.26.353656
- doi: 10.1101/2020.10.26.353656
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1101/2020.10.26.353656
info:eu-repo/semantics/OpenAccess
Mots-clés
-bio]Sujets proches
Natural science Sciences Science of science Price labels Labeling Labelling Grade labeling LabellingCiter ce document
Sylvain Lempereur et al., « ZeBraInspector, a platform for the automated segmentation and analysis of body and brain volumes in whole 5 dpf zebrafish following simultaneous visualization with identical orientations », HAL-SHS : sciences de l'information, de la communication et des bibliothèques, ID : 10.1101/2020.10.26.353656
Métriques
Partage / Export
Résumé
In recent years, the zebrafish has become a well-established laboratory model. We describe here the ZeBraInspector (ZBI) platform for high-content 3D imaging (HCI) of 5 dpf zebrafish eleuthero-embryos (EEs). This platform includes a mounting method based on 3D-printed stamps to create a grid of wells in an agarose cast, facilitating batch acquisitions with a fast-confocal laser scanning microscope. We describe reference labeling in cleared fish with a fluorescent lipophilic dye. Based on this labeling, the ZBI software registers EE 3D images, making it possible to visualize numerous identically oriented EEs on a single screen, and to compare their morphologies and any fluorescent patterns at a glance. High-resolution 2D snapshots can be extracted. ZBI software is therefore useful for diverse high-content analyses (HCAs). Following automated segmentation of the lipophilic dye signal, the ZBI software performs volumetric analyses on whole EEs and their nervous system white matter. Through two examples, we illustrate the power of these analyses for obtaining statistically significant results from a small number of samples: the characterization of a phenotype associated with a neurodevelopmental mutation, and of the defects caused by treatments with a toxic anti-cancer compound.